OmniAb (OABI) Operating Leases (2021 - 2026)
OmniAb (OABI) posted quarterly Operating Leases of $19.7 million for Q1 2026, up 5.38% year-over-year from $18.7 million in Q1 2025, and up 19.54% quarter-over-quarter from $16.5 million in Q4 2025.
OmniAb (OABI) Operating Leases (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Operating Leases for 6 consecutive years, with $19.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases rose 5.38% year-over-year to $19.7 million; the TTM figure through Mar 2026 stood at $19.7 million (up 5.38% YoY), while the FY2025 annual figure was $16.5 million, down 15.1% from the prior year.
- Operating Leases grew to $19.7 million in Q1 2026 per OABI's latest filing, from $16.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $26.2 million in Q3 2023 and bottomed at $16.5 million in Q4 2025.
- Historically, Operating Leases has averaged $21.4 million across 5 years, with a median of $21.7 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Leases soared 80.95% — and 2025, when it dropped 27.82%.
- OmniAb's Operating Leases stood at $24.0 million in 2022, then dropped by 8.08% to $22.1 million in 2023, then dropped by 12.2% to $19.4 million in 2024, then declined by 15.1% to $16.5 million in 2025, then gained by 19.54% to $19.7 million in 2026.
- Business Quant data shows OABI's Operating Leases at $19.7 million in Q1 2026, $16.5 million in Q4 2025, and $17.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.91 Mn |
| Mar 31, 2026 | 19.67 Mn |
| Dec 31, 2025 | 16.46 Mn |
| Sep 30, 2025 | 17.21 Mn |
| Jun 30, 2025 | 17.94 Mn |
| Mar 31, 2025 | 18.67 Mn |
| Dec 31, 2024 | 19.38 Mn |
| Sep 30, 2024 | 23.84 Mn |
| Jun 30, 2024 | 24.33 Mn |
| Mar 31, 2024 | 21.42 Mn |
| Dec 31, 2023 | 22.08 Mn |
| Sep 30, 2023 | 26.18 Mn |
| Jun 30, 2023 | 23.10 Mn |
| Mar 31, 2023 | 25.86 Mn |
| Dec 31, 2022 | 24.02 Mn |
| Dec 31, 2021 | 13.27 Mn |